Article
R-spondin2, a novel target of NOBOX: identification of variants in a cohort of women with primary ovarian insufficiency.
Journal of ovarian research - 25 Jul 2017
Bouilly Justine, Beau Isabelle, Barraud Sara, Bernard Valérie, Delemer Brigitte, Young Jacques, Binart Nadine
Abstract excerpt
BACKGROUND: R-spondin2 (Rspo2) is a secreted agonist of the canonical Wnt/β-catenin signaling pathway. Rspo2 plays a key role in development of limbs, lungs and hair follicles, and more recently during ovarian follicle development. Rspo2 heterozygous deficient female mice become infertile around 4 months of age mimicking primary ovarian insufficiency (POI). The study aimed to investigate the regulation of RSPO2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
